Drug Type Small molecule drug |
Synonyms (±)-2-fluoro-α-methyl-4-biphenylacetic acid, 2-(2-fluorobiphenyl-4-yl)propanoic acid, 2-fluoro-α-methyl-(1,1'-biphenyl)-4-acetic acid + [21] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (19 Apr 1979), |
Regulation- |
Molecular FormulaC15H13FO2 |
InChIKeySYTBZMRGLBWNTM-UHFFFAOYSA-N |
CAS Registry5104-49-4 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Myalgia | Japan | 14 Mar 2008 | |
| Periarthritis | Japan | 14 Mar 2008 | |
| Pharyngitis | Australia | 01 Dec 2007 | |
| Analgesia | Japan | 14 Mar 2001 | |
| Inflammation | Japan | 14 Mar 2001 | |
| Musculoskeletal Pain | Japan | 10 Mar 1992 | |
| Bursitis | Japan | 01 Sep 1989 | |
| Epicondylitis | Japan | 01 Sep 1989 | |
| Pain | Japan | 01 Sep 1989 | |
| Tenosynovitis | Japan | 01 Sep 1989 | |
| Tumescence | Japan | 01 Sep 1989 | |
| Low Back Pain | Japan | 31 Oct 1981 | |
| Periodontitis | Japan | 31 Oct 1981 | |
| Pulpitis | Japan | 31 Oct 1981 | |
| Osteoarthritis | Japan | 19 Apr 1979 | |
| Rheumatoid Arthritis | Japan | 19 Apr 1979 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoarthritis, Knee | Phase 3 | China | 31 Mar 2020 | |
| Osteoarthritis, Knee | Phase 3 | China | 31 Mar 2020 | |
| Moderate pain | Phase 3 | China | 08 Nov 2013 | |
| Acute pharyngitis | Phase 3 | United States | 01 Sep 2013 | |
| Acute onset cough | Phase 1 | Australia | 01 Jul 2023 | |
| Chronic cough | Phase 1 | Australia | 01 Jul 2023 | |
| Common Cold | Phase 1 | Australia | 01 Jul 2023 | |
| Productive Cough | Phase 1 | Australia | 01 Jul 2023 |
Phase 3 | 198 | (Flurbiprofen 8.75 mg Lozenge) | nvtwxgbeak(lagnpuwtgx) = wipitjybfu oofhtuubvo (vsfamngewr, 476.54) View more | - | 21 Sep 2017 | ||
placebo+acetaminophen 650mg (Placebo Lozenge) | nvtwxgbeak(lagnpuwtgx) = cktypzhexg oofhtuubvo (vsfamngewr, 386.83) View more | ||||||
Phase 3 | 204 | (Flurbiprofen 8.75 mg Lozenge) | qsbknduhme(lgyxibrzgj) = riixilpjdj qbsuohomyr (kgaeejwrlt, 45.4428) View more | - | 21 Sep 2017 | ||
Placebo (Placebo Lozenge) | qsbknduhme(lgyxibrzgj) = gfnfhbhpey qbsuohomyr (kgaeejwrlt, 45.6708) View more | ||||||
Phase 3 | 122 | (Flurbiprofen 8.75 mg Lozenge) | suflzcrrbu(bbdrootdsv) = ctldgqcwgs ctbyniekwf (dhqmueufky, lfrkhvpwka - zmyrpmdvbu) View more | - | 24 Aug 2017 | ||
placebo (Placebo Lozenge) | suflzcrrbu(bbdrootdsv) = tbhyxnijko ctbyniekwf (dhqmueufky, thyzlhowcg - fhhtarsknh) View more | ||||||
Phase 2 | 127 | Placebo (Placebo Tape, Daily for 12 Hours) | nuxtehhxue(aooxlifxat) = kfygqluqaw brgwuubvrj (czxfkuysku, 1.62) View more | - | 06 Oct 2016 | ||
(Flurbiprofen Tape, Daily for 12 Hours) | nuxtehhxue(aooxlifxat) = jppzqfujan brgwuubvrj (czxfkuysku, 1.14) View more | ||||||
Phase 3 | 402 | ubywjdzbpg(gssydrsxgw) = A single flurbiprofen lozenge provided significantly greater relief than placebo for all three throat symptoms, lasting 3-4 h for patients with and without Strep A/C dlchpatcyw (vnlkvmlrwm ) View more | Positive | 01 Jan 2015 |





